Literature DB >> 32431570

Recommendations for Preoperative Assessment and Shared Decision-Making in Cardiac Surgery.

Maks Mihalj1, Thierry Carrel1, Richard D Urman2, Frank Stueber3, Markus M Luedi3.   

Abstract

PURPOSE OF REVIEW: Recommendations about shared decision-making and guidelines on preoperative evaluation of patients undergoing non-cardiac surgery are abundant, but respective recommendations for cardiac surgery are sparse. We provide an overview of available evidence. RECENT
FINDINGS: While there currently is no consensus statement on the preoperative anesthetic evaluation and shared decision-making for the adult patient undergoing cardiac surgery, evidence pertaining to specific organ systems is available.
SUMMARY: We provide a comprehensive review of available evidence pertaining to preoperative assessment and shared decision-making for patients undergoing cardiac surgery and recommend a thorough preoperative workup in this vulnerable population.

Entities:  

Keywords:  Anesthesia; cardiac surgery; cardiovascular risk factors; guideline; preoperative evaluation; shared decision-making

Year:  2020        PMID: 32431570      PMCID: PMC7236882          DOI: 10.1007/s40140-020-00377-7

Source DB:  PubMed          Journal:  Curr Anesthesiol Rep        ISSN: 1523-3855


  110 in total

Review 1.  Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

Authors:  Stacy K Goergen; Gregory Rumbold; Gregory Compton; Claire Harris
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

Review 2.  Perioperative Steroid Management: Approaches Based on Current Evidence.

Authors:  Melanie M Liu; Andrea B Reidy; Siavosh Saatee; Charles D Collard
Journal:  Anesthesiology       Date:  2017-07       Impact factor: 7.892

Review 3.  Prevention of deep sternal wound infection in cardiac surgery: a literature review.

Authors:  R J Vos; B P Van Putte; G T L Kloppenburg
Journal:  J Hosp Infect       Date:  2018-06-07       Impact factor: 3.926

4.  Variation in preoperative antithrombotic strategy, severe bleeding, and use of blood products in coronary artery bypass grafting: results from the multicentre E-CABG registry.

Authors:  Fausto Biancari; Giovanni Mariscalco; Riccardo Gherli; Daniel Reichart; Francesco Onorati; Giuseppe Faggian; Ilaria Franzese; Giuseppe Santarpino; Theodor Fischlein; Antonino S Rubino; Daniele Maselli; Saverio Nardella; Antonio Salsano; Francesco Nicolini; Marco Zanobini; Matteo Saccocci; Vito G Ruggieri; Karl Bounader; Andrea Perrotti; Stefano Rosato; Paola D'Errigo; Vito D'Andrea; Marisa De Feo; Tuomas Tauriainen; Giuseppe Gatti; Magnus Dalén
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2018-10-01

5.  Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry.

Authors:  Benjamin A Steinberg; Yue Zhao; Xia He; Adrian F Hernandez; David A Fullerton; Kevin L Thomas; Roger Mills; Winslow Klaskala; Eric D Peterson; Jonathan P Piccini
Journal:  Clin Cardiol       Date:  2013-12-18       Impact factor: 2.882

6.  Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

Authors:  John W Eikelboom; Shamir R Mehta; Sonia S Anand; Changchun Xie; Keith A A Fox; Salim Yusuf
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

7.  Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.

Authors:  Jean L Rouleau; Wayne J Warnica; Richard Baillot; Pierre J Block; Sidney Chocron; David Johnstone; Martin G Myers; Cristina-Dana Calciu; Sonia Dalle-Ave; Pierre Martineau; Christine Mormont; Wiek H van Gilst
Journal:  Circulation       Date:  2007-12-10       Impact factor: 29.690

8.  Effect of Preoperative Albumin Levels on Outcomes in Patients Undergoing Left Ventricular Device Implantation.

Authors:  Pauline H Go; Arielle Hodari; Hassan W Nemeh; Jamil Borgi; David E Lanfear; Celeste T Williams; Gaetano Paone; Jeffrey A Morgan
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

9.  Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients.

Authors:  Niv Ad; Sari D Holmes; Jay Patel; Graciela Pritchard; Deborah J Shuman; Linda Halpin
Journal:  Ann Thorac Surg       Date:  2016-04-23       Impact factor: 4.330

10.  Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial.

Authors:  Jan M Dieleman; Arno P Nierich; Peter M Rosseel; Joost M van der Maaten; Jan Hofland; Jan C Diephuis; Ronald M Schepp; Christa Boer; Karel G Moons; Lex A van Herwerden; Jan G Tijssen; Sandra C Numan; Cor J Kalkman; Diederik van Dijk
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

View more
  4 in total

1.  High time for a holistic approach to perioperative care in urological surgery.

Authors:  Corina Bello; Markus M Luedi
Journal:  World J Urol       Date:  2021-04-09       Impact factor: 4.226

Review 2.  Telemedicine for preoperative assessment during a COVID-19 pandemic: Recommendations for clinical care.

Authors:  Maks Mihalj; Thierry Carrel; Igor D Gregoric; Lukas Andereggen; Pascal O Zinn; Dietrich Doll; Frank Stueber; Rodney A Gabriel; Richard D Urman; Markus M Luedi
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-05-14

3.  Shared Decision Making in Cardiovascular Patient Care to Address Cardiovascular Disease Disparities.

Authors:  Ruth-Alma N Turkson-Ocran; S Michelle Ogunwole; Anika L Hines; Pamela N Peterson
Journal:  J Am Heart Assoc       Date:  2021-10-06       Impact factor: 5.501

4.  Effect of Perioperative Lipid Status on Clinical Outcomes after Cardiac Surgery.

Authors:  Maks Mihalj; Paul Philipp Heinisch; Markus Huber; Joerg C Schefold; Alexander Hartmann; Michael Walter; Elisabeth Steinhagen-Thiessen; Juerg Schmidli; Frank Stüber; Lorenz Räber; Markus M Luedi
Journal:  Cells       Date:  2021-10-11       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.